Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy. (Q38079764)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

title

Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

0 references

Smaragdi Antonopoulou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

4

Christina Chrysohoou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Paraskevi Detopoulou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

Tzortzis Nomikos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

Elizabeth Fragopoulou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

1 reference

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

Current heart failure reports

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

122-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Epidemiology and risk profile of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

PAF exerts a direct apoptotic effect on the rat H9c2 cardiomyocytes in Ca2 -dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Baseline and 6-Week follow-up levels of PAF and activity of its metabolic enzymes in patients with heart failure and healthy volunteers--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

CDP-choline:alkylacetylglycerol cholinephosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Inhibition of PAF-acether effects on isolated guinea pig hearts by zinc ions (Zn2 ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Effect of platelet activating factor on guinea-pig papillary muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Molecular and cellular actions of platelet-activating factor in rat heart cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Platelet-activating-factor-induced changes in cardiovascular function and oxyradical status of myocardium in presence of the PAF antagonist CV-6209.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Arrhythmias caused by platelet activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Block of the background K( ) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Platelet activating factor: the good and the bad in the ischemic/reperfused heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Infection and inflammation as risk factors for thrombosis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Inflammation as an early component of atherosclerosis and vascular damage--a role for P-selectin and platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Effect of platelet activating factor on endothelial permeability to plasma macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Human platelet stimulation by acetyl glyceryl ether phosphorylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Platelets and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Signaling pathways of cardioprotective ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Gene expression profiling in peripheral blood nuclear cells in patients with refractory ischaemic end-stage heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Inflammatory cytokines in heart failure: mediators and markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Cross-sectional relationship of a Mediterranean type diet to diastolic heart function in chronic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Anti-inflammatory therapy for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

Elevated Lp-PLA 2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-013-0131-2

The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy

21 January 2018

1 reference

12 December 2020

Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta

1 reference

12 December 2020

Role of platelet-activating factor in cardiovascular pathophysiology.

1 reference

12 December 2020

Effects of platelet-activating factor on single potassium channel currents in guinea pig ventricular myocytes

1 reference

12 December 2020

Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells

1 reference

12 December 2020

Effects of platelet-activating factor antagonists WEB 2086 and BN 50730 on digoxin-induced arrhythmias

1 reference

12 December 2020

Effect of spironolactone on C-reactive protein levels in patients with heart disease

1 reference

12 December 2020

Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist

1 reference

12 December 2020

PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart

1 reference

12 December 2020

Effect of Traditional Greek Mediterranean Meals on Platelet Aggregation in Normal Subjects and in Patients with Type 2 Diabetes Mellitus

1 reference

12 December 2020

In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits

1 reference

12 December 2020

Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.

1 reference

12 December 2020

The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids.

1 reference

12 December 2020

Production and release of platelet-activating factor by the injured heart-muscle cell (cardiomyocyte)

1 reference

12 December 2020

Release of platelet-activating factor from ischemic-reperfused rabbit heart

1 reference

12 December 2020

Systemic inflammation and cell activation reflects morbidity in chronic heart failure

1 reference

12 December 2020

Effects of coronary angioplasty on plasma platelet-activating factor in man

1 reference

12 December 2020

Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity

1 reference

12 December 2020

Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats

1 reference

12 December 2020

Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages

1 reference

12 December 2020

Calcium channel blockade inhibits platelet activating factor production by human umbilical vein endothelial cells

1 reference

12 December 2020

Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)

1 reference

12 December 2020

Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart

1 reference

12 December 2020

Cardiac ultrastructural effects of the platelet-activating factor and its antagonist BN 52021

1 reference

12 December 2020

Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 activity in patients with preserved left ventricular ejection fraction

1 reference

12 December 2020

[Effects of Ginkgo biloba extract on 2 models of experimental myocardial ischemia].

1 reference

12 December 2020

Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma.

1 reference

12 December 2020

Protective effect of verapamil on the cardiac and circulatory alterations induced by platelet-activating factor

1 reference

12 December 2020

In Vitro and In Vivo Effects of Statins on Platelet-Activating Factor and Its Metabolism

1 reference

12 December 2020

Ramiprilat prevents PAF-induced myocellular and endothelial injury in a neutrophil-perfused heart preparation

1 reference

12 December 2020

Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated

1 reference

12 December 2020

Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators, and phorbol myristate acetate

1 reference

12 December 2020

Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine.

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study

1 reference

12 December 2020

Calcium influx in platelet activating factor-induced atrial natriuretic peptide release in rat cardiomyocytes

1 reference

12 December 2020

10.1007/S11897-013-0131-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 February 2020

1039184333

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23389700 AND SRC:MED&resulttype=core&format=json